Text-Size:A A A+
AndroGel, a topical medication used to treat low testosterone (Low T) levels in men, may be associated with an increased risk of heart attack, stroke and other potentially deadly heart problems. A number of AndroGel lawsuit filings have accused the manufacturers of the drug of concealing these serious side effects, and aggressively marketing the medication to men who have normal levels of testosterone as a remedy for fatigue, low sex drive and other problems merely associated with old age.
If you used this testosterone medication, you may be eligible to file an testosterone lawsuit if you experienced any serious cardiovascular side effects, including:
The attorneys at Bernstein Liebhard LLP are now offering free legal consultations to men who may have been injured by AndroGel. To find out how you might be able to obtain compensation for out-of-pocket medical bills, lost wages, pain and suffering, or other injury-related damages, please contact our Firm today for your AndroGel lawsuit review.
AndroGel is the best-selling product among numerous prescription drugs marketed to treat Low T, a condition that usually occurs in older men that can result in fatigue, low sex drive, depressed moods, an increase in body fat and decrease in muscle strength. While the U.S. Food & Drug Administration (FDA) has only approved this class of medications for men who suffer low testosterone levels that are associated with an underlying medical condition, a growing number of AndroGel lawsuits claim that these drugs are being taken by men with normal levels of the hormone due to their manufacturers’ aggressive marketing tactics.
Even before AndroGel came on the market in 2000, the FDA questioned the claims its manufacturers were making about the medication. In 1997, the FDA issued a warning letter to the company that developed AndroGel over a news release that promoted the drug for potential uses “such as the treatment of geriatric hypogonadism in elderly men.” Three years later, the FDA again warned the company that AndroGel was only approved for “primary” testicular problems and secondary problems like pituitary or hypothalamus disorders, and slammed misleading statements suggesting that it was indicated as a remedy for age-related Low T.
In January 2014, the FDA announced it was investigating AndroGel and similar drugs after two studies indicated they might be associated with an increased risk of heart attacks, strokes, and other dangerous cardiovascular side effects. Within days of the FDA notice, a number of AndroGel lawsuits had been filed in the U.S. District Court, Northern District of Illinois on behalf of patients who allegedly suffered heart attacks, strokes, heart failure, deep vein thrombosis, and pulmonary embolism due to their use of AndroGel. Legal experts expect that the number of such filings will increase as the public becomes more aware of the possible association between AndroGel and dangerous heart problems.
If you are considering filing an AndroGel lawsuit, it is important that you seek legal advice as soon as possible. The legal team at Bernstein Liebhard LLP is available now to provide you with more information about this growing litigation, and they can help you to determine if you might have a valid claim for compensation. To arrange for a free case review, please contact our office today by calling .